Rapid HPLC analysis of cefoxitin in plasma and urine. 1984

B G Charles, and P J Ravenscroft

A rapid, specific and precise method is described for the analysis of cefoxitin in plasma and urine by reversed-phase, high performance liquid chromatography (HPLC). Cefoxitin and the internal standard, 3-isobutyl-l-methyl xanthine are eluted after 5.3 and 7.5 min, respectively. The assay sensitivity limit is 1 to 2 mg/l of cefoxitin sodium at 254 nm. Commonly prescribed antibiotics do not interfere. The assay is suitable for routine monitoring and pharmacokinetic studies of cefoxitin.

UI MeSH Term Description Entries
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B G Charles, and P J Ravenscroft
June 1983, Journal of chromatographic science,
B G Charles, and P J Ravenscroft
March 1979, Research communications in chemical pathology and pharmacology,
B G Charles, and P J Ravenscroft
January 1987, Journal of pharmaceutical and biomedical analysis,
B G Charles, and P J Ravenscroft
February 1995, Die Pharmazie,
B G Charles, and P J Ravenscroft
January 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
B G Charles, and P J Ravenscroft
January 1989, Cancer chemotherapy and pharmacology,
B G Charles, and P J Ravenscroft
January 2012, Anti-inflammatory & anti-allergy agents in medicinal chemistry,
B G Charles, and P J Ravenscroft
July 2008, Biopharmaceutics & drug disposition,
B G Charles, and P J Ravenscroft
September 2007, Journal of separation science,
B G Charles, and P J Ravenscroft
January 1983, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!